F45 Training Holdings Inc. Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2023-06-30..
- Stock-based compensation / revenue · 12 months: Value 27.57%; Formula and calculation Share-based compensation / revenue. Period ending 2023-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2023-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2023-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 27.57% | Share-based compensation / revenue. Period ending 2023-06-30. $22.59M ÷ $81.95M × 100 ≈ 27.57% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 81.95M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 22.59M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -135.97M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | (m) | $81.95M | $22.59M | $-135.97M | (m) | (m) | 27.57% | (m) | (m) |
| 2023-03-31 | (m) | $92.61M | $23.34M | $-155.50M | (m) | (m) | 25.20% | (m) | (m) |
| 2022-12-31 | (m) | $104.42M | $21.32M | $-146.87M | (m) | (m) | 20.42% | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $137.29M | $92.45M | $-142.03M | (m) | (m) | 67.34% | (m) | (m) |
| 2022-03-31 | (m) | $136.42M | $90.30M | $-103.90M | (m) | (m) | 66.20% | (m) | (m) |
| 2021-12-31 | (m) | $125.22M | $88.23M | $-95.78M | (m) | (m) | 70.46% | (m) | (m) |
| 2021-09-30 | (m) | $90.25M | (m) | $-107.22M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $85.04M | (m) | $-12.05M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $82.31M | $0.00 | $-5.16M | (m) | (m) | 0.00% | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.